Form 4: SOPHIA GENETICS SA: Officer Sells Shares for Tax Withholding

SOPHIA GENETICS SA reports that President Ross Muken sold 761 ordinary shares to cover tax obligations related to vested restricted stock units, executed under a Rule 10b5-1 trading plan.

Summary

• President Ross Muken sold 761 ordinary shares of SOPHiA GENETICS SA on May 19, 2026.
• The sale was to satisfy tax withholding obligations arising from the vesting of restricted stock units on May 18, 2026.
• These transactions were conducted under a pre-established Rule 10b5-1(c) trading plan.
• The shares were sold at a weighted average price of $4.60, with individual sales ranging from $4.54 to $4.66.
• Following the sale, Muken beneficially owns 680,911 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing neutrally as it represents a routine transaction for tax purposes under a pre-arranged plan, rather than a discretionary sale or purchase indicating a strong view on the company's future.

Positives

• The sale was executed under a Rule 10b5-1(c) trading plan, indicating pre-planned and potentially less discretionary activity.
• The sale was to cover tax obligations, a common and expected event for executives receiving equity compensation.

Negatives

• A company insider, the President, has sold company stock.

Risks

• The sale, even if pre-planned, could be interpreted negatively by the market as a sign of insider confidence or lack thereof.
• The weighted average sale price of $4.60 may indicate a price point that the seller believed was opportune for tax coverage.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports on a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by SOPHiA GENETICS SA's President is a common practice to manage equity sales for tax or diversification purposes while adhering to insider trading regulations.

Stakeholder Impact

• Shareholders: The sale is a small percentage of the President's holdings and executed under a plan, so immediate impact is likely minimal. However, any insider selling can be a minor concern.
• Employees: The transaction is related to executive compensation and does not directly impact general employee compensation or benefits.
• Creditors: No direct impact on creditors is indicated by this transaction.

Next Steps

• The reporting person will continue to hold the remaining 680,911 ordinary shares.
• The company will continue to operate under its existing business strategy.

Key Dates

Keywords

SOPHIA GENETICS SA, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Rule 10b5-1, Executive Compensation, Beneficial Ownership